Streamex Appoints NYU Stern Finance Professor Anthony Marciano as Independent Director to Board and Audit Committee
summarizeSummary
Streamex Corp. appointed Anthony Marciano, a distinguished finance professor and former investment banker, as an independent director and member of the Audit Committee, enhancing the board's financial expertise and governance.
check_boxKey Events
-
New Independent Director Appointed
Anthony Marciano was appointed as an independent director to the Board of Directors, effective February 3, 2026.
-
Strong Financial and Academic Background
Mr. Marciano brings over 40 years of experience in finance and academics, including roles as a Clinical Professor of Finance at NYU Stern, and prior senior positions at Goldman Sachs, Morgan Stanley, and Drexel Burnham Lambert.
-
Joins Audit Committee
In addition to his board role, Mr. Marciano was appointed as a member of the company's Audit Committee, leveraging his deep financial expertise.
-
Compensation Details
Mr. Marciano will receive an annual cash retainer of $40,000, plus an additional $25,000 for each committee served, along with eligible annual equity compensation.
auto_awesomeAnalysis
Streamex Corp. has appointed Anthony Marciano, a highly experienced finance professional and academic, as an independent director to its Board and Audit Committee. Mr. Marciano's extensive background, including 40 years in finance, senior roles at Goldman Sachs and Morgan Stanley, and his current position as a Clinical Professor of Finance at NYU Stern, brings significant expertise in corporate finance, M&A, and financial markets. This appointment strengthens the company's governance and strategic capabilities, particularly given recent capital markets activity, including a significant insider purchase and the termination of a large equity purchase agreement. His independence and deep financial acumen are a positive signal for investors.
At the time of this filing, STEX was trading at $3.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $253.9M. The 52-week trading range was $0.40 to $14.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.